Key facts
- It has raised $20.3M.
- Notable investors include Y Combinator, StartX (US), Alchemist Accelerator, Blumberg Capital, Nova Capital (Italy) — 16 tracked in total.
- Segmed has filed 1 Form D with the SEC, most recently Nov 2022 ( sold to 18 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Segmed
- ·The full record, as it builds
Funding rounds
No funding rounds for Segmed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Segmed
Developer of a secured cloud-based platform designed to provide curated and anonymized data for medical artificial intelligence (AI) companies. The company's platform builds the infrastructure and data pipeline technology that helps to get access to de-identified, structured, and diverse medical imaging data, develop early disease detection & prediction models, and improves global healthcare, enabling medical researchers to make their findings accessible, secure, and representative of more people by making them anonymized, standardized and labeled and reduced operating burden to access therapeutic data ecosystem.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2019
- Employees
- 45
- Website
- segmed.ai/
- Ownership
- Privately Held (backing)
Segmed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Segmed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Segmed in its N-PORT filings yet. We sweep new filings monthly.